5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways
about
Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cellsA role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosisSerotonin 2B receptor is required for heart developmentResting potential, oncogene-induced tumorigenesis, and metastasis: the bioelectric basis of cancer in vivoThe serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation.Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle.Serotonin receptors and heart valve disease--it was meant 2B.Transactivation of platelet-derived growth factor receptor alpha by the GTPase-deficient activated mutant of Galpha12.A role for the serotonin transporter in hypoxia-induced pulmonary hypertension.Transmembrane potential of GlyCl-expressing instructor cells induces a neoplastic-like conversion of melanocytes via a serotonergic pathway.Functions of serotonin in hypoxic pulmonary vascular remodeling.Evolutionary forward genomics reveals novel insights into the genes and pathways dysregulated in recurrent early pregnancy lossEffect of 5-HT7 receptor blockade on liver regeneration after 60-70% partial hepatectomy.Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugs.The effect of 5-hydroxtryptamine on the regulation of megakaryocytopoiesis.Screening the receptorome reveals molecular targets responsible for drug-induced side effects: focus on 'fen-phen'.5-HT receptors on interstitial cells of Cajal, smooth muscle and enteric nerves.Serotonin and catecholamines in the development and progression of heart valve diseases.Clinical signs of fibrosis in small intestinal neuroendocrine tumours.Sonic hedgehog promotes G(1) cyclin expression and sustained cell cycle progression in mammalian neuronal precursors.Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells.Modulation of serotonergic receptor signaling and cross-talk by prion protein.Role for cellular Src kinase in myoblast proliferation.Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway.Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension.Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.5-HT(2B) antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation.Serotonin 2B receptor (5-HT2B R) signals through prostacyclin and PPAR-ß/δ in osteoblastsDifferential expression of vasoactive mediators in microparticle-challenged lungs of chickens that differ in susceptibility to pulmonary arterial hypertension.Expression of serotonin receptors in bone.Serotonin activation of the ERK pathway in Hermissenda: contribution of calcium-dependent protein kinase C.Serotonin enhances megakaryopoiesis and proplatelet formation via p-Erk1/2 and F-actin reorganization.5-Hydroxytryptamine (5HT) receptors in the heart valves of cynomolgus monkeys and Sprague-Dawley rats.Caveolin-1 affects serotonin binding and cell surface levels of human 5-HT7(a) receptors.Mechanotransduction Mechanisms in Mitral Valve Physiology and Disease Pathogenesis.Neuroendocrine tumors and fibrosis: An unsolved mystery?Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT2B receptor antagonists in vitro - a potential pathway affecting proliferation.Serotonin 2A receptor inhibition protects against the development of pulmonary hypertension and pulmonary vascular remodeling in neonatal mice.Cell Proliferation and Migration Mechanism of Caffeoylserotonin and Serotonin via Serotonin 2B receptor in Human Keratinocyte HaCaT cells.
P2860
Q24685016-188FF49E-D136-497B-B692-3FA94C07BE88Q28569215-BB4BBC7D-6306-47BC-BF0E-8A23AF50B966Q28594131-7611DBCC-E689-43FE-9388-E9D02A6B2543Q30530379-9CD7BF28-0F89-42A8-A3BB-99B6CB0492A4Q33617543-7CB10B90-5F4B-4918-A066-570D9D3D1734Q33822451-EB41F091-5225-4CDF-8ADC-A89250DD66B2Q34173511-26AE1A6E-06F0-41E9-B0BC-4B49C5F1B9B0Q34233512-D16A01CD-FBAD-4D44-B967-E7313E985F15Q34433942-406D440D-F0C2-4C77-95DC-672DD88394EEQ34435259-99C2D1A9-C716-4ED4-B18E-C608D797684EQ34653768-E9220C3F-FCDA-41F3-BE5E-E7914F269DD8Q35076576-DB9C945B-EA5C-4BE8-B4BF-E0578305F9F9Q35460340-5EC43BE4-ABC4-48D9-9F6D-69D9D8733BCDQ35919662-D83A0FC9-1F80-48AE-B2E9-42CBF8F026DFQ36223175-0434C947-2B0E-4FC2-B884-10BD30F7511AQ36415999-6AA9F3B2-E339-49FF-8E25-9D6C96BF8B85Q36544945-E6223060-8E87-4F07-A51B-B0E3CF92D8C3Q36874372-AED0DA2B-11B9-4F1B-8399-B7F951479C6DQ38634250-15CD2F18-9700-4AC5-B6FB-4FF82EB5E890Q39175786-FA50E3DE-98CE-4541-B8A3-57CA9736609AQ39457123-456F7C0D-4BF7-40F1-8CBC-4CE154143490Q39998939-D93C8354-C639-41E6-B143-467075763E99Q40482195-F3EEDAE0-CACB-43AE-9558-C6A68AFA1E8EQ40696751-95C07175-ED86-49FA-9399-155A4C13336EQ40907826-50C22900-F638-4D70-8EDC-CB39B6C207BEQ41964119-9A9767E4-75C0-4C95-BD23-7DBBD4B22E14Q42248397-DAA2BE19-0A52-4424-9C45-DBE8E618AAB3Q42424976-064E69CC-9FDD-4B8A-B1E9-1D50C37BA557Q42629276-06A332C7-03A2-4978-A72F-516E6705D526Q43244103-C5AFFE6D-5495-4AE1-8384-9E564B1E766DQ43626712-4B24A261-24E4-4467-A8A4-D2E1F96F8E2EQ43681023-09FD9F7E-146A-4DD0-AA75-34011B0E46F2Q44643430-F13DBD2F-DA7B-440B-8D85-DFD7A3740F71Q46472658-CC4FC8D4-A4A3-4DF8-A6C2-EFFB7350F956Q46950657-AC6F3609-D591-457D-9F5D-0357E43405A9Q47191844-CB1F74A3-2E01-43A0-8F85-53EF767D3707Q47720153-CE4D0E50-A4E4-433E-839A-EDB52C36A24CQ48130563-D131E2E1-29CB-4CBF-A85A-42B20A5784E6Q49975788-8379DEFB-AE57-40FC-AD57-C4CED1C27A24Q50044005-38FD0A37-A6C6-4192-8B65-B6F7663213FD
P2860
5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
5-hydroxytryptamine 2B recepto ...... with tyrosine kinase pathways
@ast
5-hydroxytryptamine 2B recepto ...... with tyrosine kinase pathways
@en
type
label
5-hydroxytryptamine 2B recepto ...... with tyrosine kinase pathways
@ast
5-hydroxytryptamine 2B recepto ...... with tyrosine kinase pathways
@en
prefLabel
5-hydroxytryptamine 2B recepto ...... with tyrosine kinase pathways
@ast
5-hydroxytryptamine 2B recepto ...... with tyrosine kinase pathways
@en
P2093
P2860
P356
P1476
5-hydroxytryptamine 2B recepto ...... with tyrosine kinase pathways
@en
P2093
P2860
P304
P356
10.1073/PNAS.050282397
P407
P577
2000-03-01T00:00:00Z